Published online Oct 28, 2014. doi: 10.4329/wjr.v6.i10.826
Revised: September 14, 2014
Accepted: September 23, 2014
Published online: October 28, 2014
Processing time: 245 Days and 16.4 Hours
Cervical spondylotic myelopathy (CSM) is the most common cause of spinal cord dysfunction and is caused by static or dynamic repeated compression of the spinal cord resulting from degenerative arthritis of the cervical spine and some biological injuries to the cervical spine. The T2 signal change on conventional magnetic resonance imaging (MRI) is most commonly associated with neurological deficits. Diffusion tensor imaging and MR spectroscopy show altered microstructure and biochemistry that reflect patient-specific pathogenesis and can be used to predict neurological outcome and response to intervention. Functional MRI can help to assess the neurological functional recovery after decompression surgery for CSM.
Core tip: This article attempts to investigate the application of magnetic resonance (MR) technology to the management of cervical spondylotic myelopathy (CSM) patients and discusses recent and future advances in both conventional and novel MR techniques. The novel MR techniques, including diffusion tensor imaging, MR spectroscopy and functional MR imaging, have all played an essential role in the management of patients with CSM.